CD123, a cell membrane protein, is notably overexpressed on AML cells, but nearly absent on normal HSCs (65),unlike CD33, but CD123 expression on blood vessels leads to off-target toxicity (66). This evidence concerns the gene CD33 and acute myeloid leukemia.